Research is being conducted on the use of low-dose aspirin to prevent preeclampsia, with studies examining its effectiveness in high-risk pregnancies and potential molecular mechanisms. Various reviews and analyses are summarizing current evidence and practices for managing preeclampsia, including the role of biomarkers and clinical implications. The relationship between low-dose aspirin and preeclampsia is being explored from multiple angles, including its impact on morbidity and mortality.